| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6191846 | European Journal of Surgical Oncology (EJSO) | 2013 | 6 Pages |
Abstract
Imatinib in locally advanced GIST is feasible and enables a high complete resection rate without tumour rupture. The combination of imatinib and surgery in patients with locally advanced GIST seems to improve PFS and OS.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
R. Tielen, C. Verhoef, F. van Coevorden, H. Gelderblom, S. Sleijfer, H.H. Hartgrink, J.J. Bonenkamp, W.T.A. van der Graaf, J.H.W. de Wilt,